SDGR - Schrodinger, Inc.

13.12
0.620   4.726%

Share volume: 1,319,027
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.72%

PREVIOUS CLOSE
CHG
CHG%
$12.50
0.62
0.05%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
14%
Profitability 2%
Dept financing 19%
Liquidity 50%
Performance 15%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
7.98%
1 Month
1.39%
3 Months
-25.62%
6 Months
-31.42%
1 Year
-39.93%
2 Year
-46.97%
Key data
Stock price
$13.12
P/E Ratio 
0.00
DAY RANGE
$12.59 - $13.20
EPS 
-$1.37
52 WEEK RANGE
$11.11 - $27.63
52 WEEK CHANGE
-$37.67
MARKET CAP 
1.317 B
YIELD 
N/A
SHARES OUTSTANDING 
73.825 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
04-30-2025
BETA 
1.27
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$1,716,636
AVERAGE 30 VOLUME 
$1,766,730
Company detail
CEO: Ramy Farid
Region: US
Website: schrodinger.com
Employees: 790
IPO year: 2020
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

Schrödinger, Inc. provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The Software segment is focused on selling its software for drug discovery in the life sciences industry. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations.

Recent news